Observational study on young adult cancer survivors
COMPRehensive Assessment of Prevalence, Risk Factors and Mechanisms of Impaired Medical and Psychosocial Health Outcomes Among Adolescents and Young Adults With Cancer: the Prospective Observational COMPRAYA Cohort Study
This study looks at young adults who have survived cancer to see how their long-term health and quality of life are affected.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4000 (estimated) |
| Ages | 18 Years to 39 Years |
| Sex | All |
| Sponsor | The Netherlands Cancer Institute Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Amsterdam, North Holland) |
| Trial ID | NCT04682470 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on young adults aged 18-39 who have survived cancer, aiming to understand the long-term health-related quality of life issues they face. It highlights the unique challenges this demographic encounters, including delays in diagnosis and the need for specialized follow-up care. By collecting data on their experiences, the study seeks to identify the psychosocial and medical impacts of survivorship. The findings may help improve care strategies for this population.
Who should consider this trial
Good fit: Ideal candidates are young adults aged 18-39 who have a confirmed diagnosis of cancer.
Not a fit: Patients who are mentally incompetent or unable to understand the Dutch language may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to enhanced support and care strategies for young adult cancer survivors, improving their quality of life.
How similar studies have performed: While there is ongoing research into cancer survivorship, this specific focus on young adults is relatively novel and underexplored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pathological confirmed cancer diagnosis; * Age 18 - 39 years at time of first cancer diagnosis; * Able to understand the informed consent form; * Provide written informed consent. Exclusion Criteria: * Mentally incompetent patients based on the opinion of treating physician . * Inability to understand the Dutch language * Life expectancy less than 6 months based on the opinion of treating physician .
Where this trial is running
Amsterdam, North Holland
- Antoni van Leeuwenhoekziekenhuis — Amsterdam, North Holland, Netherlands (Recruiting)
Study contacts
- Principal investigator: Olga Husson, Phd — Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital (NKI-AvL)
- Study coordinator: Renske Fles, Phd
- Email: r.fles@nki.nl
- Phone: +31 20 512 6993
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.